Skip to main content
SHANGHAI MICROPORT EP MEDTECH CO., LTD. logo

SHANGHAI MICROPORT EP MEDTECH CO., LTD. — Investor Relations & Filings

Ticker · 688351 ISIN · CNE100005PG9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 362 across all filing types
Latest filing 2023-08-30 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688351

About SHANGHAI MICROPORT EP MEDTECH CO., LTD.

https://www.everpace.com/

SHANGHAI MICROPORT EP MEDTECH CO., LTD. focuses on the research, development, and commercialization of medical devices for cardiac electrophysiology. The company provides a comprehensive suite of products for the diagnosis and treatment of cardiac arrhythmias, including 3D cardiac mapping systems, diagnostic catheters, and radiofrequency ablation catheters. Its core technology, the Columbus 3D EP Navigation System, enables precise localization and visualization of catheters within the heart. The product line also encompasses irrigation pumps and ablation generators designed to support minimally invasive procedures. The company aims to deliver integrated solutions that improve clinical outcomes for patients with rhythm disorders through advanced mapping and therapeutic technologies.

Recent filings

Filing Released Lang Actions
独立董事关于第三届董事会第五次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on several board meeting proposals, including the use of surplus raised funds, external investment and related party transactions, election of a non-independent director, and appointment of senior management. It references compliance with listing rules and company articles but does not contain financial statements or detailed financial data. The document is a formal opinion related to board and management decisions rather than a full report or announcement of voting results. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2023-08-30 Chinese
关于取得医疗器械注册证的自愿披露公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement by Shanghai MicroPort EP MedTech Co., Ltd. regarding the acquisition of medical device registration certificates for two products. It includes product details, registration certificate numbers, validity periods, and the impact on the company. The document is short (1065 characters) and serves as an official announcement of regulatory approval rather than a financial report or detailed operational report. It does not contain financial data, management changes, or shareholder information. It is not a report but an announcement of a regulatory milestone. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-24 Chinese
华泰联合证券有限责任公司关于上海微创电生理医疗科技股份有限公司首次公开发行部分限售股上市流通的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from Huatai United Securities regarding the listing and circulation of restricted shares following the initial public offering (IPO) of Shanghai MicroPort EP MedTech Co., Ltd. It references regulatory approvals, share issuance details, lock-up periods, shareholder commitments, and compliance with relevant securities laws and stock exchange rules. The document is not an announcement of a report but a formal verification opinion related to share listing and circulation. It does not contain financial statements or earnings data, nor is it a management or audit report. The content aligns with a Regulatory Filings (RNS) category, as it is a compliance and verification document related to securities issuance and listing rules, without fitting into more specific categories like Capital/Financing Update or Share Issue/Capital Change, which typically announce new share issues or capital changes rather than verifying share circulation post-IPO. The document length is about 3005 characters, which is substantive but not a full financial report. Therefore, the best classification is Regulatory Filings (RNS).
2023-08-22 Chinese
关于召开2023年半年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement from Shanghai MicroPort EP MedTech Co., Ltd. about the scheduling of a 2023 half-year performance explanation meeting (业绩说明会). It mentions the date, time, location, and format of the meeting, as well as instructions for investors to participate and ask questions. The document references that the company's 2023 half-year report has already been published on August 19, 2023, and this meeting is to explain and discuss that report with investors. The document itself does not contain financial statements or detailed financial data but is an announcement about the upcoming investor presentation event related to the half-year results. According to the classification rules, such announcements about investor presentations or meetings explaining financial results are classified as Investor Presentation (IP). The document length is short (1426 characters), and it is clearly an announcement of a meeting rather than the report or transcript itself. Therefore, the correct classification is Investor Presentation (IP).
2023-08-22 Chinese
关于首次公开发行部分限售股上市流通的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement regarding the listing and circulation of previously restricted shares following the company's initial public offering (IPO). It details the number of shares becoming freely tradable, the lock-up period expiration, shareholder commitments, and includes verification from the sponsoring securities firm. The document does not contain financial statements or detailed financial performance data but rather focuses on the share circulation event and compliance with regulatory requirements. The length is under 5,000 characters and it serves as a formal notice of share listing and circulation rather than a full financial report or earnings release. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements about new share issues or changes in share capital status such as restricted shares becoming tradable.
2023-08-22 Chinese
2023年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised by Shanghai MicroPort EP MedTech Co., Ltd. during the first half of 2023. It includes specifics on the amount raised, timing, usage, balance, management policies, and investment projects related to the raised funds. The document references regulatory approvals and audit reports related to the fundraising but focuses primarily on the actual use and management of the raised capital. This aligns with the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is substantive and contains detailed financial data about the fundraising and its usage, not merely an announcement or a certification. Therefore, the correct classification is CAP with high confidence.
2023-08-18 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.